All adult cancer patients enrolled in research protocols who have a pain and palliative care consult, or a recreation therapy consult at the NIH Clinical Center may be eligible for the current study. Since the AAT provided at the NIH Clinical Center is generally available to the heterogeneous cancer population (with the exception of neutropenic patients) and the primary outcome of interest is distress regardless of the type of cancer, a heterogenous sample of cancer patients is considered appropriate for this investigation. While adults are the target population for this pilot study, if results are encouraging, minors will be considered for inclusion in subsequent studies.